9 FAQs About Cancer Marker Testing
5 mins read
Cancer marker testing measures substances that may be produced by cancer cells or by the body in response to cancer.
A tumor marker test usually cannot diagnose cancer by itself because abnormal results can occur for reasons unrelated to cancer.
Doctors may use tumor markers alongside imaging, physical examination, biopsy, and other tests to support diagnosis, treatment planning, or monitoring.
The meaning of a tumor marker result depends on the specific marker, the person's health, and changes in the level over time.
Cancer marker testing looks for specific substances in blood, urine, or sometimes other body fluids or tissues. These substances, called tumor markers or biomarkers, may be produced by cancer cells or normal cells in response to cancer. Some markers are associated with particular cancers, while others can be elevated in several conditions [1].
These tests are one part of a medical assessment. Doctors may order them before, during, or after treatment. Here are nine common questions about cancer marker tests and what their results can mean.
An elevated tumor marker does not automatically mean a person has cancer, and a normal result does not completely rule it out. The key point is that a cancer marker test generally cannot confirm or exclude cancer on their own [2].
Tumor markers can rise because of noncancerous conditions, infections, inflammation, organ problems, or other factors. For this reason, doctors interpret results alongside symptoms, medical history, examination findings, imaging, and, when necessary, tissue biopsy.
Examples include prostate-specific antigen (PSA), CA-125, CA 19-9, carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and human chorionic gonadotropin (hCG) [3]. These markers can be associated with particular cancers, although some are less specific.
The table below gives examples of commonly discussed markers and their clinical uses.
Marker | Common clinical association | Possible use |
|---|---|---|
PSA | Prostate cancer | Risk assessment, diagnosis support, monitoring |
CA-125 | Ovarian cancer | Evaluation and monitoring in selected patients |
CEA | Colorectal and other cancers | Treatment monitoring and recurrence surveillance |
AFP | Liver and certain germ-cell cancers | Evaluation and monitoring |
CA 19-9 | Pancreatic and biliary cancers | Monitoring in selected cases |
hCG | Certain germ-cell cancers | Diagnosis support and treatment monitoring |
These markers are not exclusive to the cancers listed, and abnormal values can have noncancerous causes.
A doctor may recommend tumor marker testing for several reasons. It can provide additional information when cancer is suspected, help assess how a known cancer is responding to treatment, or monitor for changes after treatment.
In some cases, cancer marker test results may support decisions about further testing. Their usefulness varies, so results should be interpreted with other evidence.
Tumor marker levels may increase because of benign conditions, inflammation, infection, smoking, pregnancy, organ dysfunction, or other factors, depending on the marker [4].
For example, PSA can be affected by benign prostate enlargement and inflammation, while CA-125 can rise in some noncancerous gynecological conditions. A high tumor marker test result may prompt further evaluation, but it should not be interpreted as proof of cancer.
Some people with cancer may have marker levels within the reference range. Tumor markers can vary with cancer type and stage.
Therefore, a normal tumor marker test result should not be used by itself to reassure someone that cancer is definitely absent. If symptoms, imaging, examination findings, or other risk factors remain concerning, additional evaluation may still be needed.
Only in limited circumstances. Most tumor markers are not accurate enough to be used alone as general screening tests for people without symptoms [5]. A useful screening test needs to identify disease reliably while minimizing false-positive and false-negative results.
Routine testing without a clear medical indication can lead to unnecessary anxiety and follow-up procedures. Established screening methods, such as recommended breast, cervical, colorectal, or lung cancer screening, are generally preferred when applicable.
A cancer marker assessment requires a blood sample. Depending on the marker, testing may instead involve urine, another body fluid, or tissue. Preparation requirements vary. Some tests may require fasting or specific instructions, while others do not. It is important to follow the laboratory or doctor's instructions and provide information about medications, supplements, pregnancy, smoking, or relevant medical conditions when requested.
An abnormal result does not automatically mean cancer. Your doctor may review the result alongside symptoms, previous results, imaging studies, physical examination findings, and other laboratory tests. Depending on the situation, the next step could include repeating the test, performing imaging, or arranging a biopsy.
The number is also important, but so is the pattern over time. A single elevated value may have a different meaning from a consistently rising level. Doctors therefore avoid making major conclusions from an isolated result whenever possible.
There is no universal schedule. The timing depends on the specific marker, the cancer involved, the purpose of testing, treatment status, and the doctor's clinical judgment.
For someone receiving cancer treatment, repeated measurements may help show whether marker levels are falling, stable, or rising [6]. After treatment, testing may sometimes be used as part of surveillance for recurrence. However, marker levels must still be interpreted with other clinical information because changes do not always correspond perfectly with changes in cancer.
If you receive a tumor marker result, avoid interpreting the number in isolation. Reference ranges differ between laboratories, and the same marker can have different implications depending on why it was ordered. Your doctor may compare the result with earlier measurements and other findings before deciding whether additional testing is necessary.
Tumor marker results can be affected by factors outside the cancer itself. Laboratory methods, reference ranges, medications, and temporary health changes may influence interpretation. This is why comparing results from the same laboratory when possible can be helpful.
More importantly, patients should promptly discuss unexpected results with their healthcare professional instead of assuming that an abnormal or normal number provides a definite diagnosis.
Ask what the test is intended to determine. A marker used to monitor known cancer has a different purpose from one used while investigating symptoms.
A cancer marker test can provide useful information in selected clinical situations, particularly when it is combined with other diagnostic and monitoring tools. However, no single tumor marker result can reliably establish or exclude cancer in every person. A cancer marker test is most meaningful when interpreted in context, including the individual's symptoms, medical history, imaging, biopsy results when appropriate, and changes over time. If your doctor recommends testing, ask what marker is being measured, why it is needed, and how the result will influence the next step in your care.
